ProShare Advisors
ONEM

ProShare Advisors’s 1Life Healthcare ONEM Stock Holding History

ProShare Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,751
Closed -$430K – 1940
2022
Q4 		$430K Buy
25,751
+3,202
+14% +$54.1K ﹤0.01% 1032
2022
Q3 		$387K Sell
22,549
-539
-2% -$8.46K ﹤0.01% 1007
2022
Q2 		$181K Sell
23,088
-2,375
-9% -$20.4K ﹤0.01% 1500
2022
Q1 		$282K Sell
25,463
-4,269
-14% -$47.8K ﹤0.01% 1673
2021
Q4 		$523K Buy
29,732
+12,043
+68% +$234K ﹤0.01% 1402
2021
Q3 		$358K Sell
17,689
-15,393
-47% -$396K ﹤0.01% 1417
2021
Q2 		$1.09M Buy
33,082
+10,631
+47% +$401K ﹤0.01% 992
2021
Q1 		$877K Buy
22,451
+3,669
+20% +$172K ﹤0.01% 1071
2020
Q4 		$820K Buy
18,782
+7,900
+73% +$270K ﹤0.01% 975
2020
Q3 		$309K Buy
+10,882
New +$344K ﹤0.01% 1161

ProShare Advisors's ONEM Position: Q1 2023 in Review

ProShare Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 25,751 shares — an estimated $430K sold.

ProShare Advisors first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $1.09M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • ProShare Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • ProShare Advisors sold 25,751 1Life Healthcare shares in Q1 2023, an estimated $430K.
  • ProShare Advisors first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • ProShare Advisors's 1Life Healthcare position peaked at $1.09M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on ProShare Advisors's 13F filing for Q1 2023, filed 12 May 2023.